Conferences & Symposia

Women in Biotech

Women in Biotech

Why are women underrepresented as leaders in the biotech industry?

This symposium will explore the divide between the large number of women who pursue advanced degrees in related scientific fields and their representation in leadership positions in biotech firms. Scientists, industry and venture capital leaders, and academics will also consider new research, experimentation, and promising models that may help industry, universities, government, and private capital improve the current system.

The event is free and open to the public. Registration is required.

Contact with questions.


1 p.m.

Welcome and Opening RemarkS

Lizabeth Cohen, Dean of the Radcliffe Institute and Howard Mumford Jones Professor of American Studies, Department of History, Harvard University

Daniel Carpenter, Director of the Social Sciences Program, Radcliffe Institute, and Allie S. Freed Professor of Government in the Faculty of Arts and Sciences, Harvard University

1:15 p.m.

Defining and Analyzing the Problem

Moderator: Monica Higgins, Kathleen McCartney Professor in Education Leadership, Harvard Graduate School of Education 

Alison Wood Brooks, Assistant Professor of Business Administration, Harvard Business School

Deborah Dunsire, President and CEO, Forum Pharmaceuticals

Laurel Smith-Doerr, Professor of Sociology and Director of the Institute for Social Science Research, University of Massachusetts Amherst

2:45 p.m.


3:15 p.m.

Solutions and Strategies: What Works and What Has Not?

Moderator: Anula Jayasuriya, Founder, EXXclaim Capital; Cofounder, Evolvence India Life Science Fund and India Life Science Fund II

Victoria A. Budson, Executive Director, Women and Public Policy Program, Harvard Kennedy School

Ann DeWitt, Senior Director of Investments, Sanofi-Genzyme Bioventures

Robin Ely, Diane Doerge Wilson Professor of Business Administration and Senior Associate Dean for Culture and Community, Harvard Business School

4:45 p.m.

Closing Remarks

Janet Rich-Edwards, Codirector of the Science Program, Radcliffe Institute; Associate Professor of Medicine at Harvard Medical School; and Associate Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health

5 p.m.